Submission Details
| 510(k) Number | K250286 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 31, 2025 |
| Decision Date | July 03, 2025 |
| Days to Decision | 153 days |
| Submission Type | Traditional |
| Review Panel | Physical Medicine (PM) |
| Summary | Summary PDF |
K250286 is an FDA 510(k) clearance for the Rapid2 Magnetic Stimulators (Magstim Rapid2, Magstim Super Rapid2, Magstim Super Rapid2 Plus1), a Electromagnetic Stimulator, Pain Relief (Class II — Special Controls, product code QPL), submitted by The Magstim Company Limited (Carmarthenshire, GB). The FDA issued a Cleared decision on July 3, 2025, 153 days after receiving the submission on January 31, 2025. This device falls under the Physical Medicine review panel. Regulated under 21 CFR 882.5890.
| 510(k) Number | K250286 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 31, 2025 |
| Decision Date | July 03, 2025 |
| Days to Decision | 153 days |
| Submission Type | Traditional |
| Review Panel | Physical Medicine (PM) |
| Summary | Summary PDF |
| Product Code | QPL — Electromagnetic Stimulator, Pain Relief |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5890 |
| Definition | Intended To Apply A Magnetic-field Induced Electrical Current To Treat Pain. |